Breaking News

AAIPharma Services and CML Appoints CEO

July 8, 2014

Lonza veteran brings extensive experience

Stephan Kutzer, Ph.D. has been appointed chief executive officer of AAIPharma Services Corp. and Cambridge Major Laboratories, Inc. (CML), effective August 1st.
 
Dr. Kutzer joins the company from Lonza, Inc., where he served as chief operating officer of Lonza, Inc., part of the Lonza Group. Since 2003, he has also served as chief operating officer and/or president of several Lonza divisions, including Pharma Biotech, Custom Manufacturing, Biopharmaceuticals and Performance Chemicals. Previously, he served as site director and vice president of operations of Lonza’s Bayport, TX facilities, and was director of process improvement at Lonza Guangzhou Ltd. in China. 
 
“Stephan brings valuable leadership experience with over 18 years’ in the pharmaceutical industry. His diverse background in operations, technical services, API development and manufacturing positions him well to take our company to the next level,” said Susan Nestegard, acting chief executive officer.  “He will continue our focus on best in class safety, quality, and exceeding customer expectations to achieve our vision of being the Contract Manufacturing and Development Organization (CDMO) of first choice in the pharmaceutical sector.”

blog comments powered by Disqus
  • 16th Annual $alary $urvey

    16th Annual $alary $urvey

    Tim Wright, Editor||June 3, 2015
    Welcome to Contract Pharma’s Sixteenth Annual Salary Survey! This year’s results are derived from more than 500 respondents f

  • Newsmakers: PCI

    Newsmakers: PCI

    Tim Wright, Editor||June 2, 2015
    PCI execs talk about the recent opening of the company’s new North American clinical facility, as well as other trends in the market

  • How Sterilization of Primary Packaging Influences the Results of E&L Studies

    How Sterilization of Primary Packaging Influences the Results of E&L Studies

    Thorsten Sogding, Daniel Canton, Daniel Haines, Uwe Rothhaar, SCHOTT Pharma Services ||June 2, 2015
    As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important